Epcore Fl-2: Phase 3 trial of epcoritamab with rituximab and lenalidomide (R<SUP>2</SUP>) vs chemoimmunotherapy or R<SUP>2</SUP> in previously untreated follicular lymphoma.

Kim M. Linton, Philip Thompson, Stefano Luminari, Carla Casulo, Poliana Patah, Lingmin Zeng, J. P. Mei, Neha Dixit, Daniela Hoehn, Emmanuel Bachy

Research output: Contribution to journalMeeting Abstractpeer-review

1 Downloads (Pure)

Cite this